Ying Huang, Legend Biotech CEO

Leg­end to dou­ble Carvyk­ti pro­duc­tion as it tar­gets block­buster sta­tus 

Un­lock­ing man­u­fac­tur­ing ca­pac­i­ty will be key for Leg­end Biotech and John­son and John­son in achiev­ing their goal of reach­ing “block­buster sta­tus” for Carvyk­ti in 2025 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.